[go: up one dir, main page]

RU98100921A - HIV-1 PRIMERS - Google Patents

HIV-1 PRIMERS

Info

Publication number
RU98100921A
RU98100921A RU98100921/13A RU98100921A RU98100921A RU 98100921 A RU98100921 A RU 98100921A RU 98100921/13 A RU98100921/13 A RU 98100921/13A RU 98100921 A RU98100921 A RU 98100921A RU 98100921 A RU98100921 A RU 98100921A
Authority
RU
Russia
Prior art keywords
seq
primers
chain reaction
polymerase chain
primer
Prior art date
Application number
RU98100921/13A
Other languages
Russian (ru)
Other versions
RU2186112C2 (en
Inventor
Дон Кристоферсон Синди
Е.Квок Ширли
Лу Юй Ши-Да
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU98100921A publication Critical patent/RU98100921A/en
Application granted granted Critical
Publication of RU2186112C2 publication Critical patent/RU2186112C2/en

Links

Claims (10)

1. Олигонуклеотидный праймер, предназначенный для амплификации нуклеиновой кислоты вируса иммунодефицита человека типа 1 (ВИЧ-1), причем олигонуклеотидный праймер выбирают из группы, включающей SKCC1 (SEQ ID NO: 3) и SKCC3 (SEQ ID NO: 4).1. An oligonucleotide primer designed to amplify a nucleic acid of a human immunodeficiency virus type 1 (HIV-1), wherein the oligonucleotide primer is selected from the group consisting of SKCC1 (SEQ ID NO: 3) and SKCC3 (SEQ ID NO: 4). 2. Пара олигонуклеотидных праймеров, состоящая из SK145 (SEQ ID NO: 1) и SKCC1 (SEQ ID NO: 3) или из SK145 (SEQ ID NO: 1) и SRCC3 (SEQ NO: 4). 2. A pair of oligonucleotide primers consisting of SK145 (SEQ ID NO: 1) and SKCC1 (SEQ ID NO: 3) or SK145 (SEQ ID NO: 1) and SRCC3 (SEQ NO: 4). 3. Набор олигонуклеотидных праймеров, состоящий из пары олигонуклеотидных праймеров по п. 2 и SK145M2 (SEQ ID NO: 2). 3. A set of oligonucleotide primers, consisting of a pair of oligonucleotide primers according to claim 2 and SK145M2 (SEQ ID NO: 2). 4. Набор для обнаружения нуклеиновой кислоты вируса иммунодефицита человека типа 1 (ВИЧ-1), включающий олигонуклеотидный праймер по п. 1 или пару праймеров по п. 2, или набор праймеров по п. 3. 4. A kit for detecting a nucleic acid of a human immunodeficiency virus type 1 (HIV-1), comprising the oligonucleotide primer according to claim 1 or a pair of primers according to claim 2, or a set of primers according to claim 3. 5. Способ амплификации нуклеиновой кислоты вируса иммунодефицита человека типа 1 (ВИЧ-1), включающий осуществление полимеразной цепной реакции с использованием праймера SKCC1 (SEQ ID NO: 3) или SKCC3 (SEQ ID NO: 4). 5. A method for amplification of a nucleic acid of a human immunodeficiency virus type 1 (HIV-1), comprising carrying out a polymerase chain reaction using primer SKCC1 (SEQ ID NO: 3) or SKCC3 (SEQ ID NO: 4). 6. Способ по п. 5, где полимеразную цепную реакцию осуществляют с использованием праймеров SK145 (SEQ ID NO: 1) и SKCC1 (SEQ ID NO: 3). 6. The method according to p. 5, where the polymerase chain reaction is carried out using primers SK145 (SEQ ID NO: 1) and SKCC1 (SEQ ID NO: 3). 7. Способ по п. 6, где полимеразную цепную реакцию осуществляют также с использованием праймера SK145M2 (SEQ ID NO: 2). 7. The method of claim 6, wherein the polymerase chain reaction is also carried out using primer SK145M2 (SEQ ID NO: 2). 8. Способ по п. 5, где полимеразную цепную реакцию осуществляют с использованием праймеров SK145 (SEQ ID NO: 1) и SKCC3 (SEQ ID NO: 4). 8. The method of claim 5, wherein the polymerase chain reaction is carried out using primers SK145 (SEQ ID NO: 1) and SKCC3 (SEQ ID NO: 4). 9. Способ по п. 5, где полимеразную цепную реакцию осуществляют также с использованием праймера SK145M2 (SEQ ID NO: 2). 9. The method of claim 5, wherein the polymerase chain reaction is also carried out using primer SK145M2 (SEQ ID NO: 2). 10. Новые праймеры, способы и наборы, как они в основном представлены в данном описании. 10. New primers, methods and kits, as they are mainly presented in this description.
RU98100921/13A 1997-01-17 1998-01-16 Oligonucleotide primer, primer pair, primer set (variants), method of their using for amplification of hiv-1 nucleic acid RU2186112C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3774497P 1997-01-17 1997-01-17
US60/037744 1997-01-17

Publications (2)

Publication Number Publication Date
RU98100921A true RU98100921A (en) 1999-12-10
RU2186112C2 RU2186112C2 (en) 2002-07-27

Family

ID=21896067

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98100921/13A RU2186112C2 (en) 1997-01-17 1998-01-16 Oligonucleotide primer, primer pair, primer set (variants), method of their using for amplification of hiv-1 nucleic acid

Country Status (20)

Country Link
US (1) US5908743A (en)
EP (1) EP0854197B1 (en)
JP (1) JP2838084B2 (en)
KR (1) KR100257438B1 (en)
CN (1) CN1208469C (en)
AT (1) ATE345400T1 (en)
AU (1) AU693066B1 (en)
BR (1) BRPI9800337B8 (en)
CA (1) CA2222769C (en)
CZ (1) CZ288064B6 (en)
DE (1) DE69836395T2 (en)
DK (1) DK0854197T3 (en)
ES (1) ES2276436T3 (en)
HU (1) HU223384B1 (en)
IL (1) IL122906A (en)
NO (1) NO323157B1 (en)
PL (1) PL191989B1 (en)
RU (1) RU2186112C2 (en)
TW (1) TW400386B (en)
UA (1) UA47432C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2350650C2 (en) * 2006-04-17 2009-03-27 Общество с ограниченной ответственностью "Биосинтез" (ООО "Биосинтез") RECOMBINANT PLASMIDE DNA pVar15-HIV-LTR, CARRYING CLONED FRAGMENT GENOME HIV OF 1 TYPE FROM CONSERVATIVE SITE OF 5-LTR SEQUENCE, RECOMBINANT PLASMIDE DNA pBluKSM-HIV-LTR mod CARRYING CLONED MODIFIED FRAGMENT OF SAME SITE GENOME HIV OF 1 TYPE, TEST SET FOR QUANTITATIVE EXPRESS IDENTIFICATION OF GENOME HIV-1 OF ANY TYPE IN ASSAY AND METHOD WITH ITS USE

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19850186A1 (en) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh New primers and probes for the detection of HIV
DE19900511C2 (en) 1999-01-08 2001-03-15 Deutsches Krebsforsch Molecular biological markers for analytical electron microscopy
US6245511B1 (en) * 1999-02-22 2001-06-12 Vialogy Corp Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements
JP4965793B2 (en) * 2000-09-01 2012-07-04 ジェン−プローブ・インコーポレーテッド Amplification of HIV-1 sequences for detection of sequences associated with drug resistance mutations
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
EP1317960A1 (en) * 2001-12-06 2003-06-11 PamGene B.V. System and method for analyzing a blood sample and disposable cartridge for use in this system or method
WO2004094986A2 (en) * 2003-04-16 2004-11-04 Handylab, Inc. System and method for electrochemical detection of biological compounds
EP1792263A2 (en) 2004-09-02 2007-06-06 Vialogy Corporation Detecting events of interest using quantum resonance interferometry
US9085807B2 (en) * 2004-09-14 2015-07-21 Argos Therapeutics, Inc. Strain-independent amplification of pathogens and vaccines thereto
CN100340673C (en) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 Fluorescent quantitative detecting kit of human immune deficiency virus HIV-1 nucleic acid amplification
CN101144771B (en) * 2006-09-11 2012-05-30 中山大学达安基因股份有限公司 kit for detecting human immunodeficiency virus
WO2008119081A1 (en) 2007-03-28 2008-10-02 Signal Diagnostics System and method for high resolution analysis of nucleic acids to detect sequence variations
WO2009017743A2 (en) 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
US10669574B2 (en) 2008-11-18 2020-06-02 XCR Diagnostics, Inc. DNA amplification technology
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
HUE036963T2 (en) * 2011-06-15 2018-08-28 Grifols Therapeutics Inc Methods, compositions, and kits for determining human immunodeficiency virus (hiv)
CN105793435A (en) 2013-10-09 2016-07-20 弗洛雷森特里克公司 Multiplex probes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5386022A (en) * 1985-03-28 1995-01-31 Hoffman-La Roche Inc. Primes and probes for the amplification and detection of aids associated nucleic acids
US5389512A (en) * 1988-10-07 1995-02-14 Hoffman-La Roche Inc. Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
CA2013317A1 (en) * 1989-04-17 1990-10-17 Fred T. Oakes Diagnostic kit, primer composition and their use for replication or detection of nucleic acids
US5196305A (en) * 1989-09-12 1993-03-23 Eastman Kodak Company Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end
CA2031659A1 (en) * 1990-01-26 1991-07-27 John B. Findlay Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
JP4108118B2 (en) * 1993-03-26 2008-06-25 ジェン−プローブ・インコーポレイテッド Detection of human immunodeficiency virus type 1
CA2167838C (en) * 1993-07-23 1999-11-23 Thomas B. Ryder Methods for enhancing nucleic acid amplification
WO1995014109A1 (en) * 1993-11-19 1995-05-26 U.S. Department Of The Army High through-put quantitative polymerase chain reaction for hiv clinical specimens
US5665545A (en) * 1994-11-28 1997-09-09 Akzo Nobel N.V. Terminal repeat amplification method
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5702926A (en) * 1996-08-22 1997-12-30 Becton, Dickinson And Company Nicking of DNA using boronated nucleotides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2350650C2 (en) * 2006-04-17 2009-03-27 Общество с ограниченной ответственностью "Биосинтез" (ООО "Биосинтез") RECOMBINANT PLASMIDE DNA pVar15-HIV-LTR, CARRYING CLONED FRAGMENT GENOME HIV OF 1 TYPE FROM CONSERVATIVE SITE OF 5-LTR SEQUENCE, RECOMBINANT PLASMIDE DNA pBluKSM-HIV-LTR mod CARRYING CLONED MODIFIED FRAGMENT OF SAME SITE GENOME HIV OF 1 TYPE, TEST SET FOR QUANTITATIVE EXPRESS IDENTIFICATION OF GENOME HIV-1 OF ANY TYPE IN ASSAY AND METHOD WITH ITS USE

Similar Documents

Publication Publication Date Title
RU98100921A (en) HIV-1 PRIMERS
ATE394410T1 (en) HIGHLY SPECIFIC PRIMERS, AMPLIFICATION PROCESSES AND KITS
KR100901084B1 (en) Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2, methods of use thereof and a kit comprising the same
DK0403333T3 (en) Nucleotide sequences derived from the genome of HIV-1, HIV-2 and SIV retroviruses and their use, preferably for
CA2296144A1 (en) Oligonucleotide primers for efficient detection of hepatitis c virus (hcv) and methods of use thereof
SI0887427T1 (en) Amplification and detection of hiv-1 and/or hiv-2
CA2169315A1 (en) Primers and probes for the detection of hiv
EP1034302A4 (en) De novo or "universal" sequencing array
CA2183758A1 (en) Human papilloma virus detection in a nucleic acid amplification process using general primers
EP0854197A3 (en) Primers for the detection of HIV-1
AU3054502A (en) Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
WO2000029611A3 (en) Novel primers and probes for detecting hiv
EP1010759A4 (en) Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
EP1193313A4 (en) METHOD FOR SUBTYPING HIV-1
CA2296072A1 (en) Oligonucleotide primers for efficient reverse transcription of hepatitis c virus (hcv) rna and methods of use thereof
RU93013954A (en) METHOD FOR DETECTING THE VIRUS OF IMMUNODEFICIENCY
RU98107390A (en) METHOD FOR HEPATITIS C VIRUS IDENTIFICATION IN HUMAN BLOOD SERUM
TH28996B (en) Specific oligonucleotides for hepatitis C virus